A carregar...
Cardiotoxicity Monitoring in Patients Treated with Tyrosine Kinase Inhibitors
Tyrosine kinase inhibitors (TKIs) can cause cardiotoxicity, and some suggest routine monitoring of cardiac function during TKI use. We describe two cases of TKI‐induced heart failure (HF) that suggest the utility of monitoring with laboratory tests is questionable. One patient developed HF 5 days af...
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6656470/ https://ncbi.nlm.nih.gov/pubmed/30971480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0891 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|